Entrar/Registro  
HOME SPANISH
 
Medicina Crítica
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Medicina Crítica >Year 2009, Issue 3


Tamez A, Guillén N, Castorena G
Multiple amebic liver abscess
Rev Asoc Mex Med Crit y Ter Int 2009; 23 (3)

Language: Español
References: 20
Page: 165-172
PDF: 163.51 Kb.


Full text




ABSTRACT

In Mexico amoebiasis is a very frequent disease, however amoebic extraintestinal locations as the amoebic liver abscess (ALA), have become scarce since the appearance of potent amoebicidal drugs as metronidazol in 1950. Although very little is known about the clinical outcome of these cases, their current incidence ranges from 90 to 200 cases per year. Most ALA are isolated lesions, mainly located in the right lobe and commonly heal with a proper medical treatment. We report two recent cases admitted to our Intensive Care Unit (ICU), with a fatal outcome. Besides their clinical features we present a bibliographic review and a therapeutic algorithm to study and treat patients with multiple hepatic cystic lesions is proposed.


Key words: Amoebic liver abscess in UTI, serious extraintestinal amoebiasis.


REFERENCIAS

  1. histolytica, revisión. Rev Med Chile 2008;136:118-124.

  2. Marín E, Pinilla AE, López MC. Absceso hepático amebiano. Revisión de 100 años de esta patología en Colombia. Acta Med Colomb 2000;25:218-226.

  3. Fonte L. Amebas y amebiasis: aspectos conceptuales e históricos. En: Amebiasis: enfoques actuales sobre su diagnóstico, tratamiento y control. La Habana: 2000: 15-24.

  4. 10Who/Paho/Unesco Report. A consultation with experts on amoebiasis. Mexico City, Mexico 28-29 January 1997. Epidemiol Bull 1997;18:13-14.

  5. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986;8:228-238.

  6. Secretaría de Salud. Epidemiología. Información epidemiológica de morbilidad. Secretaría de Salud, México DF, 2000:15-32.

  7. Ximénez C. Epidemiology of amebiasis in México: A molecular approach. Arch Med Res 2006;37:263-265.

  8. Ximénez C, Morán P. Amibiasis intestinal: estado actual del conocimiento. Medicina Interna de México 2007;23 (5):398-407.

  9. Frederick JR, Petri WA Jr. Roles for the galactose/N-acetylgalactosamine binding lectin of Entamoeba in parasite virulence and differentiation. Glycobiology 20005;15: 53R-59R.

  10. Leippe M, Bruhn H, Hecht O, Grotzinger J. Ancient weapons: the three-dimensional structure of amoebopore A. Trends Parasitol 2005;21:5-7.

  11. Petri WA Jr. Pathogenesis of amebiasis. Curr Opin Microbiol 2002;5:443-447.

  12. Campell D, Chadee K. Interleukin (IL)2, IL-4 and tumor necrosis factor-alpha responses during Entamoeba histolytica liver abscess development in gerbils. J Infect Dis 1997;175:1176-1183.

  13. Ackers J, Mirelman D. Progress in research on Entamoeba histolytica pathogenesis. Curr Opin Microbiol 2006;9:367-373.

  14. Jaramillo-Luna R, Campos RR, Tsutsumi V. Participation of neutrophils, macrophages, and endothelial cells in the amebic liver lesion in the mouse. Arch Med Res 2000;31:S231-S233.

  15. Seydel KB, Smith SJ, Stanley SL, Jr. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model disease. Infect Immun 2000;68:400-402.

  16. Banchereau J, Briere F, Caux C, Dovoust J, Lebecque S, Liu YD et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.

  17. Haque R, Mollah NU, Ali IK, Alam K, Eubanks A, Lyerly D, Petri WA Jr. Diagnosis of amebic liver abscess and intestinal infection with the Tech Lab Entamoeba histolytica ll antigen detection and antibody test. J Clin Microbiol 2000; 38:3235-3239.

  18. Fonte L. Amebas y amebiasis: aspectos conceptuales e históricos, enfoques actuales sobre su diagnóstico, tratamiento y control. La Habana: 2000:15-24.

  19. Domínguez J, Mucio M. Drenaje laparoscópico del absceso hepático. Cirugía y Cirujanos 2006;74(3): 189-194.

  20. Pons J. Liver lesion. Rev Enf Dig 2004;96(8):567-577.

  21. Pinilla AE, López MC. Historia del Protozoo Entamoeba histolytica, revisión. Rev Med Chile 2008;136:118-124.

  22. Marín E, Pinilla AE, López MC. Absceso hepático amebiano. Revisión de 100 años de esta patología en Colombia. Acta Med Colomb 2000;25:218-226.

  23. Fonte L. Amebas y amebiasis: aspectos conceptuales e históricos. En: Amebiasis: enfoques actuales sobre su diagnóstico, tratamiento y control. La Habana: 2000: 15-24.

  24. 10Who/Paho/Unesco Report. A consultation with experts on amoebiasis. Mexico City, Mexico 28-29 January 1997. Epidemiol Bull 1997;18:13-14.

  25. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986;8:228-238.

  26. Secretaría de Salud. Epidemiología. Información epidemiológica de morbilidad. Secretaría de Salud, México DF, 2000:15-32.

  27. Ximénez C. Epidemiology of amebiasis in México: A molecular approach. Arch Med Res 2006;37:263-265.

  28. Ximénez C, Morán P. Amibiasis intestinal: estado actual del conocimiento. Medicina Interna de México 2007;23 (5):398-407.

  29. Frederick JR, Petri WA Jr. Roles for the galactose/N-acetylgalactosamine binding lectin of Entamoeba in parasite virulence and differentiation. Glycobiology 20005;15: 53R-59R.

  30. Leippe M, Bruhn H, Hecht O, Grotzinger J. Ancient weapons: the three-dimensional structure of amoebopore A. Trends Parasitol 2005;21:5-7.

  31. Petri WA Jr. Pathogenesis of amebiasis. Curr Opin Microbiol 2002;5:443-447.

  32. Campell D, Chadee K. Interleukin (IL)2, IL-4 and tumor necrosis factor-alpha responses during Entamoeba histolytica liver abscess development in gerbils. J Infect Dis 1997;175:1176-1183.

  33. Ackers J, Mirelman D. Progress in research on Entamoeba histolytica pathogenesis. Curr Opin Microbiol 2006;9:367-373.

  34. Jaramillo-Luna R, Campos RR, Tsutsumi V. Participation of neutrophils, macrophages, and endothelial cells in the amebic liver lesion in the mouse. Arch Med Res 2000;31:S231-S233.

  35. Seydel KB, Smith SJ, Stanley SL, Jr. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model disease. Infect Immun 2000;68:400-402.

  36. Banchereau J, Briere F, Caux C, Dovoust J, Lebecque S, Liu YD et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.

  37. Haque R, Mollah NU, Ali IK, Alam K, Eubanks A, Lyerly D, Petri WA Jr. Diagnosis of amebic liver abscess and intestinal infection with the Tech Lab Entamoeba histolytica ll antigen detection and antibody test. J Clin Microbiol 2000; 38:3235-3239.

  38. Fonte L. Amebas y amebiasis: aspectos conceptuales e históricos, enfoques actuales sobre su diagnóstico, tratamiento y control. La Habana: 2000:15-24.

  39. Domínguez J, Mucio M. Drenaje laparoscópico del absceso hepático. Cirugía y Cirujanos 2006;74(3): 189-194.

  40. Pons J. Liver lesion. Rev Enf Dig 2004;96(8):567-577.






>Journals >Medicina Crítica >Year 2009, Issue 3
 

· Journal Index 
· Links 






       
Copyright 2019